Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Tamara Ghanem

- PMLiVE

Nerve centre gives Novartis edge in clinical trials

Algorithms predict potential delays

- PMLiVE

Novartis aims for 10 blockbuster launches by 2020

Includes new gene therapy Zolgensma

- PMLiVE

IQVIA sees market slowdown looming for pharma

Growth rates dip below the 6% average

- PMLiVE

Another amyloid bust as Roche pulls crenezumab trials

Undermines amyloid hypothesis hopes. including Biogen candidate

Lighthouse Medical Communications US goes large in the Big Apple

It’s a double celebration for Lighthouse Medical Communications US, a Lucid Group Company, as it celebrated its four-year anniversary, coupled with a move to impressive new offices in Financial District, Manhattan,...

Lucid Group Communications Limited

- PMLiVE

Horizon taps academic partner to boost gene editing platform

Partners with Rutgers University to license base editing tech

- PMLiVE

Medicines will take priority over food in no-deal Brexit

The UK is more reliant on the EU for medicines than food, says Hancock

- PMLiVE

UK biotech booms in 2018, despite Brexit worries

Industry attracted a record-breaking £2.2bn in investment last year

- PMLiVE

New hires at Ferring, Flexion and Immunocore

The latest movers in pharma

- PMLiVE

Q&A: Pernille Laerkegaard Hansen

Gemma Jones interviews AstraZeneca's Senior Research Director, Head of Bioscience

- PMLiVE

Imbruvica and Gazyvo approved in first non-chemo CLL use

Further boost for blockbuster leukaemia drug

- PMLiVE

Hardy returns to Genentech as CEO

In other news, Vertex fires chief operating officer

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links